Dentsply buys dental implant company:
This article was originally published in Clinica
Executive Summary
Dentsply is to buy German company Friadent, a manufacturer of dental implants, for around $100 million. Mannheim-based Friadent has the largest market share in dental implants in Germany and holds the number two position in Europe, the company claims. The acquisition will add around $41 million in annual sales to York, Pennsylvania-based Dentsply. In addition, it provides access to broader markets for Dentsply's P-15 bone growth stimulant. At the same time, Dentsply plans to sell its InfoSoft subsidiary, which develops and sells products for dental practice management, to PracticeWorks.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.